EUVIMEDEUVIMED entdecken
Open Access

Intermittent Low-Magnitude Pressure Applied Across Macroencapsulation Devices Enables Physiological Insulin Delivery Dynamics

Ella A Thomson, Sooyeon Lee, Haixia Xu, Hannah Moeller, Joanna Sands, Rayhan A Lal, Justin P Annes iD, Ada S Y Poon iD

Diabetes · 2025

DOI: 10.2337/db24-0818 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, 2025. Verfasst von Ella A Thomson und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Electrical Engineering, Stanford University, Stanford, CA. Hauptthemen laut MEDLINE: Insulin, Diabetes Mellitus, Type 1, Islets of Langerhans Transplantation, Hypoglycemic Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: AOU NIH HHS, NIDDK NIH HHS, Stanford Graduate Fellowship.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cadaveric islet and stem cell–derived transplantation hold promise as treatments for type 1 diabetes. To tackle the issue of immunocompatibility, numerous cellular macroencapsulation techniques that use diffusion to transport insulin across an immunoisolating barrier have been developed. However, despite several devices progressing to human clinical trials, none have successfully attained physiological glucose control or insulin independence. Based on empirical evidence, macroencapsulation methods with multilayered, high islet surface density are incompatible with on-demand insulin delivery and physiological glucose regulation when solely reliant on diffusion. An additional driving force is essential to overcome the distance limit of diffusion. In this study, we present both theoretical evidence and experimental validation that applying pressure, at levels comparable to physiological diastolic blood pressure, significantly enhances insulin flux across immunoisolation membranes, increasing it by nearly three orders of magnitude. This significant enhancement in transport rate allows for precise, subminute regulation of both bolus and basal insulin delivery. By incorporating this technique with a pump-based extravascular system, we demonstrate the ability to rapidly reduce glucose levels in diabetic rodent models, replicating the timescale and therapeutic effect of subcutaneous insulin injection or infusion. This advance provides a potential path toward achieving insulin independence with islet macroencapsulation. Article Highlights Numerous islet macroencapsulation techniques use diffusion to transport insulin across an immunoisolating barrier. Despite some devices reaching clinical trials, none have achieved physiological glucose control or insulin independence. Empirical evidence shows that high-density islet macroencapsulation methods cannot achieve on-demand insulin delivery and glucose regulation with diffusion alone. An additional driving force is needed. Appling a subminute pressure at physiological levels can achieve on-demand insulin delivery from macroencapsulated islets and glucose regulation. Incorporating pressure-based enhancements in macroencapsulation systems could lead to successful clinical outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

InsulinDiabetes Mellitus, Type 1Islets of Langerhans TransplantationHypoglycemic AgentsDiabetes Mellitus, ExperimentalAnimalsBlood GlucoseRatsPressureMiceInsulin Infusion SystemsDrug Delivery SystemsIslets of LangerhansHumansMale

Substanzen

InsulinBlood GlucoseHypoglycemic Agents

Autor:innen und Institutionen

  • Department of Electrical Engineering, Stanford University, Stanford, CA.
  • Division of Endocrinology, Department of Medicine, Stanford University, Stanford, CA.
  • Stanford Diabetes Research Center, Stanford, CA.
  • Division of Endocrinology, Department of Pediatrics, Stanford University, Stanford, CA.
  • Safran ChEM-H, Stanford University, Stanford, CA.

ORCID-Profile: Justin P Annes, Ada S Y Poon

Förderung

  • AOU NIH HHS
  • NIDDK NIH HHS
  • Stanford Graduate Fellowship
  • Stanford Bio-X Bowes Fellowship
  • Stanford SystemX Alliance
  • Stanford Bio-X Interdisciplinary Initiatives Seed Grants Program (IIP)
  • All of Us Research Program

Zitieren

APA

Thomson, E. A., Lee, S., Xu, H., Moeller, H., Sands, J., Lal, R. A., Annes, J. P., & Poon, A. S. Y. (2025). Intermittent Low-Magnitude Pressure Applied Across Macroencapsulation Devices Enables Physiological Insulin Delivery Dynamics. Diabetes. https://doi.org/10.2337/db24-0818

Vancouver

Thomson EA, Lee S, Xu H, Moeller H, Sands J, Lal RA, et al. Intermittent Low-Magnitude Pressure Applied Across Macroencapsulation Devices Enables Physiological Insulin Delivery Dynamics. Diabetes. 2025. doi:10.2337/db24-0818

BibTeX
@article{Thomson2025,
  author = {Thomson, Ella A and Lee, Sooyeon and Xu, Haixia and Moeller, Hannah and Sands, Joanna and Lal, Rayhan A and Annes, Justin P and Poon, Ada S Y},
  title = {Intermittent Low-Magnitude Pressure Applied Across Macroencapsulation Devices Enables Physiological Insulin Delivery Dynamics},
  journal = {Diabetes},
  year = {2025},
  doi = {10.2337/db24-0818}
}
Kostenlos starten →